MMP9 and cancer: The literature shows that the proteolytic activity of metalloproteinase 9 (MMP-9) increases during the acute phases of inflammation, suggesting its role as a biological barrier in the early stages and its potential protective function in certain pathological situations, such as colitis-associated cancer [38].